Genetics of the neuronal ceroid lipofuscinoses

Current Opinion in Genetics and Development

Volumn 10, Issue 3, 2000, Pages 299-305

  Peltonen, Leena ^a,b,c   Savukoski, Minna ^b,c   Vesa, Jouni ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

LYSOSOME ENZYME; MEMBRANE PROTEIN;

CHROMOSOME 11P; CHROMOSOME 16P; CHROMOSOME 1P; GENE DELETION; GENE LOCUS; GENE MUTATION; GENETIC LINKAGE; HUMAN; MOLECULAR GENETICS; NEURONAL CEROID LIPOFUSCINOSIS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW;

EID: 0034122825     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(00)00086-1     Document Type: Review

References (69)

1. Zeman W., Donahue S., Dyken P., Green J. The neuronal ceroid-lipofuscinosis (Batten-Vogt syndrome). Vinken P., Bruyn G. Handbook of Clinical Neurology. 1970;588-679.
2. Santavuori P. Neuronal ceroid-lipofuscinoses in childhood. Brain Dev. 10:1988;80-83.
3. Uvebrandt P., Hagberg B. Neuronal ceroid lipofuscinoses in Scandinavia Epidemiology and clinincal pictures. Neuropediatrics. 28:1997;6-8.
4. Rapola J. Neuronal ceroid-lipofuscinoese in childhood. Landing B.H., Hause M.D., Bernstein J., Rosenberg H.S. Genetic Metabolic Diseases. Genet Metab Dis Perspect Pediatr Pathol. 1993;7-44 Karger, Basel.
5. Autti T., Raininko R., Launes J., Nuutila A., Santavuori P. Jansky-Bielschowsky variant disease: CT, MRI and SPECT findings. Pediatr Neurol. 8:1992;121-126.
6. th Edn. 2000;David McGraw Hill, New York. in press.
7. Winchester B. The Lysosome: structure organization and function, Fundamentals of medical cell biology: membranology and subcellular organs. 1992;JAI Press, London.
8. Rapola J., Salonen R., Ämmälä P., Santavuori P. Prenatal diagnosis of infantile neuronal ceroid lipofuscinosis, INCL: morphological aspects. J Inher Metab Dis. 16:1993;349-352.
9. Hall N.A., Lake B.D., Dewji N.N., Patrick A.D. Lysosomal storage of subunit c of mitochondrial ATP synthase in Batten’s disease (ceroid lipofuscinosis). J Biochem. 275:1991;269-272.
10. Palmer D.N., Fearnley I.M., Walker V.E., Hall N.A., Lake B.D., Wolfe L.S., Haltia M., Martinus R.D., Jolly R.D. Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease). Am J Metab Dis. 42:1992;561-567.
11. Tyynelä J., Suopanki J., Santavuori P., Baumann M., Haltia M. Variant late infantile neuronal ceroid-lipofuscinoses: pathology and biochemistry. J Neuropathol Exp Neurol. 56:1997;369-375.
12. Tyynelä J., Palmer D.N., Baumann M., Haltia M. Storage of saposin A and D in neuronal ceroid lipofuscinosis. FEBS Lett. 330:1993;8-12.
13. Tyynelä J., Baumann M., Henseler M., Sandhoff K., Haltia M. Sphinogolipid activator proteins (SAPs) are stored together with glycosphingolipids in the infantile neuronal ceroid-lipofuscinoses. Am J Med Genet. 57:1995;294-297.
14. O'Brien J.S., Krets K.A., Dewji N., Wenger D.A., Esch F., Fluharty A.L. Coding of two sphingolipid activator proteins (SAP-1 and SAP2) by same genetic locus. Science. 241:1988;1098-1101.
15. M1 activator. Biochem. 27:1988;4557-4564.
16. Mehl E., Jazkewits H. Eine cerebrosidsupfatase aus schweineniere. Hoppe-Seyler’s Z Physiol Chem. 339:1964;260-276. [Title translation: Cerebrosidesulphatase of the swine brain.].
17. O'Brien J.S., Kishimoto Y. Saposin proteins: structure, function and role in human lysosomal storage disorders. FASEB J. 5:1991;301-308.
18. Järvelä I., Schleutker J., Haataja L., Santavuori P., Puhakka L., Manninen T., Palotie A., Sandkuijl L.A., Renlund M., White R., Aula P., Peltonen L. Infantile neuronal ceroid lipofuscinosis (CLN1) maps to the short arm of chromosome 1. Genomics. 9:1991;170-173.
19. Sharp J.D., Wheeler R.B., Lake B.D., Savukoski M., Järvelä I.E., Peltonen L., Gardiner R.M., Williams R.E. Loci for classical and a variant late infantile neuronal ceroid lipofuscinosis map to chromosomes 11p15 and 15q21-23. Hum Mol Genet. 6:1997;591-595.
20. Gardiner M., Sandford A., Deadman M., Poulton J., Cookson W., Reeders S., Jokiaho I., Peltonen L., Eiberg H., Julier C. Batten disease (Spielmeyer-Vogt disease, juvenile onset neuronal ceroid-lipofuscinosis) gene (CLN3) maps to human chromosome 16. Genomics. 8:1990;387-390.
21. Savukoski M., Kestilä M., Williams R., Järvelä I., Sharp J., Harris J., Santavuori P., Gardiner M., Peltonen L. Defined chromosomal assignment of CLN5 demonstrates that at least four genetic loci are involved in the pathogenesis of human ceroid lipofuscinoses. Am J Hum Genet. 55:1994;695-701.
22. Wheeler R.B., Sharp J.D., Mitchell W.A., Bate S.L., Williams R.E., Lake B.D., Gardiner R.M. A new locus for variant late infantile neuronal ceroid lipofuscinosis - CLN7. Mol Genet Metab. 66:1999;337-338.
23. Haltia M., Tyynelä J., Hirvasniemi A., Herva R., Ranta S., Lehesjoki A-E. Northern epilepsy. Goebel H.H., Mole S.E., Lake B.D. The Neuronal Ceroid Lipofuscinosis (Batten disease). 1998;117-124 IOS press, Amsterdam.
24. Haltia M. Infantile neuronal ceroid lipofuscinosis: neuropathological aspects. D Armstrong J.A.R. Ceroid-Lipofuscinosis (Batten’s Disease). 1982;105-115 Elsevier Biomedical Press, Amsterdam.
25. Vesa J., Hellsten E., Verkruyse L.A., Camp L.A., Rapola J., Santavuori P., Hofmann S.L., Peltonen L. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature. 376:1995;584-587.
26. Camp L.A., Hofmann S.L. Purification and properties of a palmitoyl-protein thioesterase that cleaves palmitate from H-Ras. J Biol Chem. 268:1993;22566-22574.
27. Hancock J.F., Magee A.I., Childs J.E., Marshall C.J. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell. 57:1989;1167-1177.
28. Hellsten E., Vesa J., Olkkonen V.M., Jalanko A., Peltonen L. Human palmitoyl protein thioesterase: evidence for lysosomal targeting of the enzyme and disturbed cellular routing in infantile neuronal ceroid lipofuscinosis. EMBO J. 15:1996;5240.
29. Verkruyse L.A., Hofmann S.L. Lysosomal targeting of palmitoyl-protein thioesterase. J Biol Chem. 271:1996;15831.
30. Heinonen O., Kyttälä A., Lehmus E., Paunio T., Peltonen L., Jalanko A. Expression of palmitoyl protein thioesterase in neurons. Mol Gen Metab. 69:2000;123-129.
31. Wisniewski K.E., Becerra C.R., Hofmann S.L. A novel granular variant (GROD) from a late infantile neuronal ceroid lipofuscinosis (CLN2) is an infantile form (CLN1) when biochemically studied. J Neuropathol Exp Neurol. 56:1997;94.
32. Das A.K., Becerra C.H.R., Yi W., Lu J-L., Siakotos A.N., Wisniewski K.E., Hofmann S.L. Molecular genetics of palmitoyl-protein thioesterase deficiency in the US. J Clin Invest. 102:1998;361-370.
33. Mitchison H.M., Hofmann S.L., Becerra C.H.R., Munroe P.B., Lake B.D., Crow Y.J., Stephenson J.B., Williams R.E., Hofman I.L., Taschner P.E.M.et al. Mutations in the palmitoyl-protein thioesterase gene (PPT; CLN1) causing juvenile neuronal ceroid lipofuscinosis with granular osmiophilic deposits. Hum Mol Genet. 7:1998;291-297.
34. Bellizzi J.J., Widom J., Kemp C., Lu J-Y., Das A.K., Hofmann S.L., Clardy J. The crystal structure of palmitoyl-protein thioesterase-1 and the molecular basis of infantile neuronal ceroid lipofuscinosis. Proc Natl Acad Sci USA. 2000;. in press. The authors describe the three-dimensional structure of PPT and show that the mutations resulting in the severe, INCL phenotype disturb the active site buried in the molecule, whereas the mutations resulting in the milder JNCL phenotype affect the amino acids in the periphery of the molecule.
35. Sleat D.E., Donnelly R.J., Lackland H., Liu C-G., Sohar I., Pullarkat R., Lobel P. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science. 277:1997;1802-1805.
36. Vines D.J., Warburton M.J. Classical late infantile neuronal ceroid lipofuscinosis fibroblast are deficient in lysosomal tripeptidyl peptidase I FEBS. Lett. 443:1999;131-135.
37. Sleat D.E., Gin R.M., Sohar I., Wisniewski K., Sklower-Brooks S., Pullarkat R.K., Palmer D.N., Lerner T.J., Boustany R.M., Uldall P.et al. Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storag disorder. Am J Hum Genet. 64:1999;1511-1523.
38. Isolation of a novel gene underlying Batten disease, CLN3. Cell. 82:1995;949.
39. Järvelä I., Sainio M., Rantamäki T., Olkkonen V.M., Carpen O., Peltonen L., Jalanko A. Biosyntesis and intracellular targeting of the CLN3 protein defective in Batten disease. Hum Mol Genet. 7:1998;85-90.
40. Pearce D.A., Ferea T., Nosel S.A., Das B., Sherman F. Action of TEN1, the yeast orthologue of the gene mutated in batten disease. Nat Genet. 22:1999;55-58. The authors demonstrate elegantly how a model organism, yeast, can be used to provide more understanding of the biological function of a molecule. The deletion mutant of the yeast orthologue was found to be resistant to the chemical aminonitrophenyl propanediol when grown at low pH and this resistance was complemented by human CLN3. These findings provide evidence for a yeast othologue for the Batten gene and offers an approach to analyze the molecular pathway, defective in JNCL, using the yeast model.
41. Pearce D.A., Sherman F. BTN1, a yeast gene corresponding to the human gene responsible for Batten’s disease, is not essential for viability, mitochondrial function, or degradation of mitochondrial ATP synthase. Yeast. 13:1997;691-697.
42. Boehme D.H., Cottrell J.C., Leonberg S.C., Zeman W. A dominant form of neuronal ceroid-lipofuscinosis. Brain. 94:1971;745-760.
43. Berkovic S.F., Carpenter S., Andermann F., Andermann E., Wolfe L.S. Kufs' disease: a critical reappraisal. Brain. 111:1988;27-62.
44. Savukoski M., Klockars T., Holmberg V., Santavuori P., Lander E.S., Peltonen L. CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. Nat Genet. 19:1998;286-288. The authors of this paper describe the positional cloning of the gene mutated in the variant of LINCL. Large-scale sequencing and transcript prediction of the critical DNA region provides the basis for the mutation identification in vLINCL patients. Just as in JNCL, a gene with no homologies in databases encoding a protein with membrane-spanning domains was identified.
45. William R.E., Topcu M., Lake B.D., Mitchell W., Mole S.E. Turkish variant late infantile NCL. Goebel H.H., Mile S.E., Lake B.D. The Neuronal Ceroid Lipofuscinosis (Batten Disease). 1999;114-116 IOS Press, Amsterdam.
46. Hirvasniemi A., Lang H., Lehesjoki A-E., Leisti J. Northern epilepsy syndrome: an inherited childhood onset epilepsy with associated mental deterioration. J Med Genet. 31:1994;177-182.
47. Ranta S., Zhang Y., Ross B., Lonka Takkunen E., Messer A., Sharp J., Wheeler R., Kusumi K., Mole S., Liu W.et al. The neuronal ceroid lipofuscinoses in human EPMR and MND mutant mice are associated with mutations in CLN8. Nat Genet. 23:1999;233-236. A new subtype of NCL disorder is identified when the causative gene for Northern epilepsy is identified by a positional cloning strategy. The mutation in the mouse orthologue is found in MND mice, described earlier as a naturally occurring mouse model for NCL disorders. The gene encodes a protein with unknown function but predicted transmembrane domains.
48. Greene N.D.E., Bernard D.L., Taschner P.E.M., Lake B.D., de Vos N., Breuning M.H., Gardiner R.M., Mole S.E., Nussbaum R.L., Mitchison H.M. A murine model for juvenile NCL: gene targeting of mouse CLN3. Mol Genet Metab. 66:1999;309-313.
49. Katz M.L., Shibuya H., Liu P.C., Kaur S., Gao C.L., Johnson G.S. A mouse gene knockout model for juvenile ceroid-lipofuscinosis (Batten disease). J Neurosci Res. 57:1999;551-556.
50. Mitchison H.M., Bernard D.J., Greene N.D., Cooper J.D., Junaid M.A., Pullarkat R.K., de Vos N., Breuning M.H., Owens J.W., Mobleyet al. Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. Neurobiol Dis. 6:1999;321-334.
51. Mole S.E. Batten disease: four genes and still counting. Neurobiol Disease. 5:1998;287-303.
52. Palmer D.N., Tyynela J., van Mil H.C., Westlake V.J., Jolly R.D. Accumulation of sphingolipid activator proteins (SAPs) A and D in granular osmiophilic deposits in miniature Schnauzer dogs with ceroid-lipofuscinosis. J Inher Metab Dis. 20:1997;74-84.
53. Shibuya H., Liu P.C., Katz M.L., Siakotos A.N., Nonneman D.J., Johnsson G.S. Coding sequence and exon/intron organization of the canine CLN3 (Batten Disease) gene and its exclusion as the locus for ceroid-lipofuscinosis in English setter dogs. J Neurosci Res. 52:1998;268-275.
54. Riis R.C., Cummings J.F., Loew E.R., de Lahunta A. Tibetan terrier model of canine ceroid lipofuscinosis. Am J Med Genet. 42:1992;615-621.
55. Broom M.F., Zhou C., Broom J.E., Barwell K.J., Jolly R.D., Hill D.F. Ovine neuronal ceroid lipofuscinosis: a large animal model syntenic with the human neuronal ceroid lipofuscinosis variant CLN6. J Med Genet. 35:1998;717-721.
56. Järplid B., Haltia M. An animal model of the infantile type of neuronal ceroid lipofuscinosis. J Inher Metab Dis. 16:1993;274-277.
57. Bronson R.T., Donahue L.R., Johnson K.R., Tanner A., Lane P.W., Faust J.R. Neuronal ceroid lipofuscinosis (nclf), a new disorder of the mouse linked to chromosome 9. Am J Med Genet. 77:1998;289-297.
58. Bronson R.T., Lake B.D., Cook S., Taylor S., Davisson M.T. Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten’s disease). Ann Neurol. 33:1993;381-385.
59. MacLeod P.M., Nag S., Berry C. Ultrastructural studies as a method of prenatal diagnosis of neuronal ceroid lipofuscinosis. Am J Med Genet. 5(Suppl):1988;93-97.
60. Rapola J., Salonen R., Ämmälä P., Santavuori P. Prenatal diagnosis of the infantile type of neuronal ceroid lipofuscinosis by electron microscopic investigation of human chorionic villi. Prenat Diagn. 10:1990;553-559.
61. Järvelä I. Infantile neuronal ceroid lip0ofuscinosis (CLN1): linkage disequilibrium in the Finnish population and evidence that variant late infantile form (variant CLN2) represents a nonallelic locus. Genomics. 10:1991;333-337.
62. Järvelä I.E., Mitchison H.M., Munroe P.B., O'Rawe A.M., Mole S.E., Syvänen A-C. Rapid disgnostic test for the major mutation underlying Batten disease. J Med Genet. 33:1996;1041-1042.
63. Munroe P.B., Rapola J., Mitchison H.M., Mole S.E., Gardiner R.M., Järvelä I.E. Prenatal diagnosis of Batten disease. Lancet. 347:1996;1014-1015.
64. Rapola J., Lähdetie J., Isosomppi J., Helminen P., Penttinen M., Järvelä I. Prenatal diagnosis of variant late infantile neuronal ceroid lipofuscinosis (vLINCL; CLN5). Prenat Diagn. 19:1999;685-688.
65. Voznyi Y.V., Keulemans J.L.M., Mancini G.M.S., Catsman-Berrevoets C.E., Young E., Winchester B., Kleijer W.J., van Diggelen O.P. A new simple enzyme assay for pre- and postnatal diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) and its variants. J Med Genet. 36:1999;471-474.
66. Berry-Kravis E., Sleat D.E., Sohar I., Meyer P., Donnelly R., Lobel P. Prenatal testing for late infantile neuronal ceroid lipofuscinosis. Ann Neurol. 47:2000;254-257.
67. Lake B.D., Young E.P., Winchester B.G. Prenatal diagnosis of lysosomal storage diseases. Brain Pathol. 8:1998;133-149.
68. Eiberg H., Gardiner R.M., Mohr J. Batten disease (Spielmeyer-Sjögren disease) and haptoglobins (HP): indication of linkage and assignment to chromosome 16. Clin Genet. 36:1989;217-218.
69. Tahvanainen E., Ranta S., Hirvasniemi A., Karila E., Leisti J., Sistonen P., Weissenbach J., Lehesjoki A-E., de la Chapelle A. The gene for recessively inherited human childhood progressive epilepsy with mental retardation maps to the distal short arm of chromosome 8. Proc Natl Acad Sci USA. 91:1994;7267-7270.